Elsa Melloni

Via Lillo Del Duca 11
Bresso, 20091, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A quantitative proteomic approach to evaluate the efficacy of carnosine in a murine model of chronic obstructive pulmonary disease (COPD).

A quantitative proteomic approach to evaluate the efficacy of carnosine in a murine model of chronic obstructive pulmonary disease (COPD).

Journal: Redox biology

Published: September 09, 2024

Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model.

Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: May 07, 2024

In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation.

In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation.

Journal: International journal of molecular sciences

Published: March 23, 2023

Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs.

Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs.

Journal: Scientific reports

Published: June 24, 2022

Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches.

Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches.

Journal: Expert review of neurotherapeutics

Published: August 08, 2020

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.

Journal: Neuropharmacology

Published: November 06, 2019

Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.

Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.

Journal: Experimental neurology

Published: October 29, 2019

Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.

Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.

Journal: Neuropharmacology

Published: October 25, 2019

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.

Journal: The Journal of pharmacology and experimental therapeutics

Published: September 12, 2017

Evaluation of the effects of a new intravaginal gel, containing purified bovine colostrum, on vaginal blood flow and vaginal atrophy in ovariectomized rat.

Evaluation of the effects of a new intravaginal gel, containing purified bovine colostrum, on vaginal blood flow and vaginal atrophy in ovariectomized rat.

Journal: Sexual medicine

Published: October 31, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026